About this trial
The study is to evaluate the accuracy and safety of a novel real-time continuous glucose and ketone monitoring system among adult patients with type 1 diabetes mellitus (T1DM) with respect to Yellow Spring Instrument (YSI) and Randox reference venous plasma sample measurements.
Eligibility criteria
Qualifiers
Age ≥ 18 years
Diagonsed with T1DM on Continuous subcutaneous insulin infusion (CSII)
Venous blood sampling access can be established in the forearm
Capable of independently reading instructions and complying with the clinical trial requirements
Disqualifiers
Severe hypoglycemia within the past 6 months
A diagnosed history of Diabetic ketoacidosis (DKA) in the past 3 months
Heart failure or hemiplegic sequelae due to prior cerebrovascular disease
Severe skin conditions at the sensor wear site
Trial design
Treatments tested in this trial
- GK5 CGKM
Treatment groups
Locations
2Sponsors and collaborators
Henan University of Science and Technology
Lead sponsor